Ali BOZKURT, Osman KÖSE, TUNAY KARLIDERE, Murat ERDEM, Mehmet AK, K. Nahit ÖZMENLER

Seboreik dermatitli hastalarda aleksitimi

Amaç: Seboreik dermatit (SD) emosyonel etkenlerden etkilenebilen bir hastalıktır. SD hastalarında aleksitimik özelliklerle ilgili araştırma yoktur. Bu çalışmada SD hastalarında aleksitiminin yaygınlığını ve bu hastalardaki depresyon ve anksiyete düzeyleri ile aleksitiminin ilişkisini belirlemek amaçlanmıştır. Yöntem: Eksen I psikiyatrik bozukluğu bulunmayan 30SD hastası ile 30 sağlıklı birey, aleksitimi düzeyleri ile anksiyete ve depresyon belirtilerinin şiddeti yönünden karşılaştırıldı. Sonuçlar: SD grubunda kontrol grubuna göre depresif belirti ve sürekli anksiyete düzeyi ile aleksitimi düzeyi yüksek bulundu. Toronto Aleksitimi Ölçeği’ne göre, SD grubunun %36.7’si (s=11), kontrol grubunun %10.0’ı (s=3) aleksitimikti. SD grubunda aleksitimi puanları ile anksiyete düzeyleri (sürekli ve durumsal) ve depresif belirtilerin şiddeti arasında pozitif bağıntı vardı. Aleksitiminin sürekli anksiyete ile ilişkisi durumsal anksiyeteye göre daha anlamlıydı. Tartışma: SD hastalarının değerlendirilmesinde aleksitiminin ve aleksitimi ile emosyonel etkenlerin karmaşık ilişkisinin dikkate alınması gerekmektedir. Bu konuda daha kapsamlı çalışmalara gereksinim vardır.

Alexithymia in patients with seborrhoeic dermatitis

Objective: Seborrhoeic dermatitis (SD) is one of the dermatological diseases affected by psychological factors, and the psychodermatological patients are characterized by alexithymia. But there is no research about alexithymia in SD patients. It was aimed to identify the prevalence of alexithymia and the correlation of alexithymia with severity of depressive symptoms and levels of state and trait anxiety in a sample of SD patients. Methods: Thirty SD patients with no concomitant psychiatric axis I disorders and a control group (CG) (30 healthy subjects) matched for age, gender and education level were compared in terms of alexithymia (TAS-20; 20-item version of Toronto Alexithymia Scale), anxiety (STAI; the State-Trait Anxiety Inventory) and depressive symptoms (BDI; the Beck’s Depression Inventory). Results: SD patients had significantly greater levels of trait anxiety and alexithymia scores and more severe depressive symptoms than CG. According to TAS-20, 36.7% (n=11) of SD patients and 10.0% (n=3) of CG were alexithymic, and the rate of alexithymics in the CG was significantly lower than in the SDP. Alexithymia scores were positively correlated with anxiety levels (both state and trait) and severity of depressive symptoms in SD patients. In addition, the alexithymia had tightest relationship with the depressive symptom severity, and the relationship of alexithymia with trait anxiety was tighter than that of state anxiety. Conclusion: Although more extensive studies are required, alexithymia and it’s complex relationship with emotional distress should be taken into consideration as confounding factors while evaluating the patients with seborrhoeic dermatitis.

PDF

___

1. Mercan S, Kıvanç Altunay İ. Psikiyatri ve Dermatolojinin ortak çalışma alanı: Psikodermatoloji. Türk Psikiyatri Dergisi 2006;17: 305-313
2. DeAngelis YM, Gemmer CM, Kaczvinsky JR, Kennealy DC, Schwartz JR, Dawson TL. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J Investig Dermatol Symp Proc 2005; 10:295-297.
3. Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician 2006; 74: 125-130.
4. Picardi A, Abeni D. Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom 2001; 70:118-136.
5. Richards HL, Fortune DG, Griffiths CE, Main CJ. Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. J Psychosom Res 2005; 58:89-96.
6. Poot F, Sampogna F, Onnis L. Basic knowledge in psychodermatology. J Eur Acad Dermatol Venereol 2007; 21:227-234.
7. Costa A, Peppe A, Carlesimo GA, Salamone G, Caltagirone C. Alexithymia in Parkinson’s disease is related to severity of depressive symptoms. Eur J Neurol 2006;13:836-841.
8. Freyberger H. Supportive psychotherapeutic techniques in primary and secondary alexithymia. Psychother Psychosom 1977; 28: 337-342.
9. Öztaş P, Çalikoğlu E, Çetin I. Psychiatric tests in seborrhoeic dermatitis. Acta Derm Venereol 2005; 85:68-69.
10. Bergbrant IM. Seborrhoeic dermatitis and Pityrosporum ovale: Cultural, immunological and clinical studies. Acta Derm Venereol Suppl 1991; 167:1-36.
11. Önder M, Coşar B, Öztaş MO, Candansayar S. Stress and skin diseases in musicians: evaluation of the beck depression scale, general psychologic profile (the brief symptom inventory [BSI]), beck anxiety scale and stressful life events in musicians. Biomed Pharmacother 2000; 54:258-262.
12. Kessler RC. Sociology and psychiatry. HI Kaplan, BJ Sadock (Eds.), Comprehensive Textbook of Psychiatry, sixth ed., Baltimore, Williams & Wilkins, 1995,p.356-359.
13. Kaplan GA, Roberts RE, Camacho TC, Coyne JC. Psychosocial predictors of depression. Prospective evidence from the human population laboratory studies. Am J Epidemiol 1987; 125: 206-220.
14. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571.
15. Spielberger CD, Gorsuch RL, Lushene RE. STAI: Manual for the State-Trait Anxiety Inventory. California, Consulting Psychological Press Inc., Palo Alto, 1970.
16. Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale-I: Item selection and crossvalidation of the factor structure. J Psychosom Res 1994;38: 23-32.
17. Bagby RM, Taylor GJ, Parker JD. The twenty-item Toronto Alexithymia Scale-II: Convergent, discriminant and concurrent validity. J Psychosom Res 1994; 38:33-40.
18. Çorapçıoğlu A, Aydemir O, Yıldız M, Esen A, Köroğlu E. Structured Clinical Interview for DSM-IV (SCID), Turkish version, Ankara, Hekimler Yayin Birligi, 1999.
19. First MB, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV(SCID). Washington, DC, APA,1997.
20. Hisli N. Reliability and validity of Beck Depression Inventory among university students. J Turkish Psychology 1989; 7:3-13.
21. Öner N, Le Compte A. Durumluk-Sürekli Kaygı Envanteri El Kitabı. Istanbul, Boğaziçi Üniversitesi Yayınları, 1985.
22. Sayar K, Güleç H, Ak İ. Validity and reliability of the twenty-item Toronto Alexithymia Scale (Turkish version). 37th National Congress of Psychiatry, Istanbul, 2001.
23. Cordan Yazıcı A, Başterzi A, Tot Acar S, Üstünsoy D, İkizoğlu G, Demirseren D, et al. Alopecia areata and alexithymia. Turk Psikiyatri Derg 2006; 17:101-106.
24. Consoli SM, Rolhion S, Martin C, Ruel K, Cambazard F, Pellet J, et al. Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis. Dermatology 2006; 212:128-136.
25. Salminen JK, Saarijarvi S, Aarela E, Toikka T, Kauhanen J. Prevalence of alexithymia and its association with sociodemographic variables in the general population of Finland. J Psychosom Res 1999; 46:75-82.
26. Maietta G, Fornaro P, Rongioletti F, Rebora A. Patients with mood depression have a high prevalence of seborrhoeic dermatitis. Acta Derm Venereol 1990;70:432-434.
27. Picardi A, Mazzotti E, Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol 2006; 54:420-426.
28. Misery L, Touboul S, Vinçot C, Dutray S, Rolland-Jacob G, Consoli SG, et al. Stress and seborrheic dermatitis. Ann Dermatol Venereol 2007; 134:833-837.
29. Chahraoui K, Pinoit JM, Viegas N, Adnet J, Bonin B, Moreau T. Alexithymia and links with depression and anxiety in multiple sclerosis. Rev Neurol (Paris) 2008;164:242-245.
30. Picardi A, Porcelli P, Mazzotti E, Fassone G, Lega I, Ramieri L, et al. Alexithymia and global psychosocial functioning: a study on patients with skin disease. J Psychosom Res 2007; 62:223-229.
31. Duddu V, Isaac MK, Chaturvedi SK. Alexithymia in somatoform and depressive disorders. J Psychosom Res 2003; 54:435-438.
32. Çelikel FC, Saatçioğlu O. Alexithymia and anxiety in female chronic pain patients. Ann Gen Psychiatry 2006;5:13.
33. Mattila AK, Salminen JK, Nummi T, Joukamaa M. Age is strongly associated with alexithymia in the general population. J Psychosom Res 2006; 61:629-635.
34. Karlıdağ R, Ünal S, Evereklioğlu C, Sipahi B, Er H, Yoloğlu S. Stressful life events, anxiety, depression and coping mechanisms in patients with Behçet's disease. J Eur Acad Dermatol Venereol 2003; 17:670-675.
35. Berthoz S, Consoli S, Perez-Diaz F, Jouvent R. Alexithymia and anxiety: compounded relationships? A psychometric study. Eur Psychiatry 1999; 14:372-378.
36. Mueller J, Alpers GW. Two facets of being bothered by bodily sensations: anxiety sensitivity and alexithymia in psychosomatic patients. Compr Psychiatry 2006; 47:489-495.
37. Peters RM, Lumley MA. Relationship of alexithymia to cardiovascular disease risk factors among African Americans. Compr Psychiatry 2007; 48:34-41.